VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones

Virology

Volumn 374, Issue 2, 2008, Pages 444-452

  Filippone, Claudia ^a   Zhi, Ning ^a   Wong, Susan ^a   Lu, Jun ^a   Kajigaya, Sachiko ^a   Gallinella, Giorgio ^b   Kakkola, Laura ^c   Söderlund Venermo, Maria ^c   Young, Neal S ^a   Brown, Kevin E ^d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF HELSINKI   (Finland)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Infectious clone; Parvovirus B19; PLA2 like motif

Indexed keywords

AMINO ACID; PHOSPHOLIPASE A2; PROTEIN VP1U; VIRUS DNA; VIRUS ENZYME; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SUBSTITUTION; ARTICLE; CATALYSIS; CLONE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA REPLICATION; DNA TRANSFECTION; ENZYME ACTIVITY; GENE SEQUENCE; GENOME ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PLASMID; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; VIRUS CAPSID; VIRUS GENOME; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; WILD TYPE;

AMINO ACID SEQUENCE; CAPSID PROTEINS; CELL LINE; CHILD; CLONING, MOLECULAR; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PARVOVIRUS B19, HUMAN; PHOSPHOLIPASES A2; SEQUENCE ANALYSIS, DNA;

MIRIDAE; PARVOVIRUS;

EID: 42649126717     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.01.002     Document Type: Article

References (43)

1. Anderson M.J., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., and Tyrrell D.A. Experimental parvoviral infection in humans. J. Infect. Dis. 152 (1985) 257-265
2. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L.R., Cohen B.J., Mortimer P.P., and Pereira M.S. Human parvovirus, the cause of erythema infectiosum (fifth disease)?. [letter]. Lancet i (1983) 1378
3. Blundell M.C., Beard C., and Astell C.R. In vitro identification of a B19 parvovirus promoter. Virology 157 (1987) 534-538
4. Brown K.E., Anderson S.M., and Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262 (1993) 114-117
5. Brown K.E., Green S.W., Antunez de Mayolo J., Bellanti J.A., Smith S.D., Smith T.J., and Young N.S. Congenital infection with B19 parvovirus associated with constitutional anemia and pure red cell aplasia. Blood 82 Suppl 1 (1993) 311a Ref type: abstract
6. Brunstein J., Soderlund-Venermo M., and Hedman K. Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19. Virology 274 (2000) 284-291
7. Canaan S., Zadori Z., Ghomashchi F., Bollinger J., Sadilek M., Moreau M.E., Tijssen P., and Gelb M.H. Interfacial enzymology of parvovirus phospholipases A2. J. Biol. Chem. 279 (2004) 14502-14508
8. Cotmore S.F., McKie V.C., Anderson L.J., Astell C.R., and Tattersall P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J. Virol. 60 (1986) 548-557
9. Deiss V., Tratschin J.D., Weitz M., and Siegl G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology 175 (1990) 247-254
10. Doerig C., Hirt B., Antonietti J.P., and Beard P. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J. Virol. 64 (1990) 387-396
11. Dorsch S., Liebisch G., Kaufmann B., von Landenberg P., Hoffmann J.H., Drobnik W., and Modrow S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 76 (2002) 2014-2018
12. Fan M.M., Tamburic L., Shippam-Brett C., Zagrodney D.B., and Astell C.R. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner. Virology 291 (2001) 285-291
13. Hirt B. Selective extraction of polyoma DNA from infected mouse cells. J. Mol. Biol. 26 (1967) 365-369
14. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfeld S., Anderson L.J., Shimada T., and Young N.S. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4646-4650
15. Kinney J.S., Anderson L.J., Farrar J., Strikas R.A., Kumar M.L., Kliegman R.M., Sever J.L., Hurwitz E.S., and Sikes R.K. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J. Infect. Dis. 157 (1988) 663-667
16. Kurtzman G., Frickhofen N., Kimball J., Jenkins D.W., Nienhuis A.W., and Young N.S. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321 (1989) 519-523
17. Kurtzman G.J., Cohen B., Meyers P., Amunullah A., and Young N.S. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet ii (1988) 1159-1162
18. Lu J., Zhi N., Wong S., and Brown K.E. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J. Infect. Dis. 193 (2006) 582-590
19. Luo W., and Astell C.R. A novel protein encoded by small RNAs of parvovirus B19. Virology 195 (1993) 448-455
20. Matsumura M. Parvovirus-associated arthritis. Am. J. Med. 111 (2001) 241
21. Moffatt S., Yaegashi N., Tada K., Tanaka N., and Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J. Virol. 72 (1998) 3018-3028
22. Momoeda M., Wong S., Kawase M., Young N.S., and Kajigaya S. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J. Virol. 68 (1994) 8443-8446
23. Moore T.L. Parvovirus-associated arthritis. [In Process Citation]. Curr. Opin. Rheumatol. 12 (2000) 289-294
24. Mortimer P.P., Humphries R.K., Moore J.G., Purcell R.H., and Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302 (1983) 426-429
25. Nguyen Q.T., Wong S., Heegaard E.D., and Brown K.E. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301 (2002) 374-380
26. Ozawa K., Ayub J., Hao Y.S., Kurtzman G., Shimada T., and Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 61 (1987) 2395-2406
27. Ozawa K., Ayub J., Kajigaya S., Shimada T., and Young N. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J. Virol. 62 (1988) 2884-2889
28. Ozawa K., and Young N. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol. 61 (1987) 2627-2630
29. Pattison J.R., Jones S.E., Hodgson J., Davis L.R., White J.M., Stroud C.E., and Murtaza L. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet i (1981) 664-665
30. Raab U., Beckenlehner K., Lowin T., Niller H.H., Doyle S., and Modrow S. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3. Virology 293 (2002) 86-93
31. Ros C., Gerber M., and Kempf C. Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity. J. Virol. 80 (2006) 12017-12024
32. Rosenfeld S.J., Yoshimoto K., Kajigaya S., Anderson S., Young N.S., Field A., Warrener P., Bansal G., and Collett M.S. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J. Clin. Invest. 89 (1992) 2023-2029
33. Saikawa T., Anderson S., Momoeda M., Kajigaya S., and Young N.S. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J. Virol. 67 (1993) 3004-3009
34. Serjeant G.R., Topley J.M., Mason K., Serjeant B.E., Pattison J.R., Jones S.E., and Mohamed R. Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent. Lancet ii (1981) 595-597
35. Shimomura S., Komatsu N., Frickhofen N., Anderson S., Kajigaya S., and Young N.S. First continuous propagation of B19 parvovirus in a cell line. Blood 79 (1992) 18-24
36. St Amand J., and Astell C.R. Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19. Virology 192 (1993) 121-131
37. St Amand J., Beard C., Humphries K., and Astell C.R. Analysis of splice junctions and in vitro and in vivo translation potential of the small, abundant B19 parvovirus RNAs. Virology 183 (1991) 133-142
38. Wong S., and Brown K.E. Development of an improved method of detection of infectious parvovirus B19. J. Clin. Virol. 35 (2006) 407-413
39. Young N.S., and Brown K.E. Parvovirus B19. N. Engl. J. Med. 350 (2004) 586-597
40. Zadori Z., Szelei J., Lacoste M.C., Li Y., Gariepy S., Raymond P., Allaire M., Nabi I.R., and Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 1 (2001) 291-302
41. Zhi N., Mills I.P., Lu J., Wong S., Filippone C., and Brown K.E. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J. Virol. 80 (2006) 5941-5950
42. Zhi N., Rikihisa Y., Kim H.Y., Wormser G.P., and Horowitz H.W. Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J. Clin. Microbiol. 35 (1997) 2606-2611
43. Zhi N., Zadori Z., Brown K.E., and Tijssen P. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318 (2004) 142-152